stella
beta
Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma — Stella
Home
/
Prognostic Biomarker
/
Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma
View on ClinicalTrials.gov
Recruiting
Back to Prognostic Biomarker trials
Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma
Trial locations
(1 site)
Belgium
Ghent University Hospital, Ghent